Tuhina Neogi, MD, PhD

@Tuhina_Neogi

Rheumatologist & Epidemiologist Researcher in osteoarthritis & gout Professor of Medicine & of Epidemiology,

Vrijeme pridruživanja: travanj 2018.

Tweetovi

Blokirali ste korisnika/cu @Tuhina_Neogi

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Tuhina_Neogi

  1. proslijedio/la je Tweet
    30. sij

    Join the Rheumatism Society of DC for Gout 2020. Wednesday February 12. Looking forwards to hosting

    Poništi
  2. proslijedio/la je Tweet
    29. sij

    SWHR enjoyed hosting experts on and and we are eager to continue our engagement in this topic and raise awareness of the gaps in research, treatment, and care. Thank you and for joining us!

    Poništi
  3. proslijedio/la je Tweet

    The ACR is now accepting applications for the 2020 Rheumatology Research Workshop. Early career investigators are encouraged to apply for this opportunity. The deadline to apply is Feb. 10. Learn more →

    Poništi
  4. 28. sij

    Fun day with at panel meeting on pain & understanding sex differences. Huge knowledge gaps and research agenda identified. 1st steps for clinical studies: report data stratified by sex. 1st steps for basic studies: report sex of animals studied.

    Poništi
  5. proslijedio/la je Tweet
    28. sij

    Dear Friends, here is my 2nd video on "Who Gets Myositis" in the for patients series, where I talk about how common is myositis as well as age, gender, race/ethnicities, etc of myositis. Next video is on risk factors of myositis - any guesses?

    Poništi
  6. proslijedio/la je Tweet
    27. sij

    Come work with us at ! Applications open for our NIH funded T32! There are citizenship requirements so take a look at the app and please reach out with questions 😃👩‍💻👨‍🔬

    Poništi
  7. proslijedio/la je Tweet
    28. sij

    FY 2020 Funding Plan | NIAMS Updated January 24, 2020 "The interim funding plan below for research and training grants represents the most current information as of the date cited above"

    Poništi
  8. proslijedio/la je Tweet
    28. sij

    Down on your knees. Symptomatic or radiographic knee increases (2X) risk of all‐cause mortality. Increased risk of mortality partially mediated through its effect on disability and physical effects on quality of life.

    Poništi
  9. proslijedio/la je Tweet
    27. sij

    In epidemiology, women make up the majority of first authors but cited far less than male authors: Study by et al. looks at gender disparities in the field.

    Poništi
  10. proslijedio/la je Tweet
    26. sij

    -Target UA<6, ⬆️allopurinol to >300mg if needed even in CKD, start low dose and ⬆️as needed, consider screening Asians/Blacks for HLAB*5801 as that ⬆️ risk for sev allergic rxn. Nephrologists should lead CKD gout mgmt as CKD pts are affected more and often under Rx

    Poništi
  11. proslijedio/la je Tweet
    25. sij

    Our paper on antihypertensive drug and risk from the trial is out! Amlodipine lowers risk compared to Lisinopril! Helpful for tx in adults with gout.

    Poništi
  12. 25. sij

    Yes!! The message is getting out: Updated guidelines: Don’t let kidney function dictate dosing | MDedge Rheumatology ⁦

    Poništi
  13. 24. sij

    Good luck to our medical colleagues on the frontlines managing this outbreak. (The majority of transmissions for SARS and MERS was nosocomial)

    Prikaži ovu nit
    Poništi
  14. 24. sij

    Coronavirus outbreak in China: reminds me of when I was a medical trainee in Toronto during SARS - I was scared to go to work. Toronto Board of Health did a great job - importance of public health and . Another Decade, Another Coronavirus

    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    23. sij
    Poništi
  16. 23. sij

    Today was a great clinic. Laughter, hugs, & was ~on time! And always satisfying to aspirate a nodule, see the chalky material, identify the crystals, & start mgmt to help address decades-long untreated symptoms. I never tire of seeing crystals under the microscope!

    Poništi
  17. 23. sij

    Know of a project manager looking for a new opportunity? Come work with us on exciting -related projects!

    Poništi
  18. proslijedio/la je Tweet
    22. sij

    PRF News--Nav1.7 Channels in DRG Neurons: Where Are They and How Do They Get There? A new study provides the first live visualization, with single-molecule resolution, of Nav1.7 distribution and trafficking along primary afferents.

    Poništi
  19. proslijedio/la je Tweet
    22. sij

    Dear Friends, as promised - here is the first video for myositis patients explaining - What is Myositis? In series I will post 1 myositis video each week to promote myositis awareness. Subscribe to YouTube channel Myositis101 for the updates.

    Poništi
  20. proslijedio/la je Tweet

    The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·